Abstract
Genetic testing plays an increasing role in the diagnosis of various diseases every year. Special attention is paid to genes with an increased risk of cancer in case of mutation. Hereditary prostate cancer is usually more aggressive and is most often associated with mutations in DNA repair genes. These mutations carriers have an increased risk of metastasis and a shorter life expectancy. The study of mutations in the BRCA1/BRCA2 genes is most often used in clinical practice, while there are many other genes responsible for DNA repair processes that have not been sufficiently studied. In this paper, we report a review of literature sources studying the cellular mechanisms of functioning of DNA repair genes, the effect of such mutations on the disease state and oncological outcomes.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
